Cargando…

HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression

OBJECTIVE: As part of a larger study to understand how Envelope N-glycosylation influences HIV-1 pathogenesis, we selected a participant infected with a single Subtype C variant and determined whether deletion of specific potential N-glycan sites (PNGs) impacted Envelope function longitudinally. RES...

Descripción completa

Detalles Bibliográficos
Autores principales: Lumngwena, Evelyn Ngwa, Shuping, Liliwe, Bernitz, Netanya, Woodman, Zenda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580609/
https://www.ncbi.nlm.nih.gov/pubmed/31208438
http://dx.doi.org/10.1186/s13104-019-4375-0
_version_ 1783428054456991744
author Lumngwena, Evelyn Ngwa
Shuping, Liliwe
Bernitz, Netanya
Woodman, Zenda
author_facet Lumngwena, Evelyn Ngwa
Shuping, Liliwe
Bernitz, Netanya
Woodman, Zenda
author_sort Lumngwena, Evelyn Ngwa
collection PubMed
description OBJECTIVE: As part of a larger study to understand how Envelope N-glycosylation influences HIV-1 pathogenesis, we selected a participant infected with a single Subtype C variant and determined whether deletion of specific potential N-glycan sites (PNGs) impacted Envelope function longitudinally. RESULTS: We deleted five PNGs previously linked to HIV-1 transmission of two matched Envelope clones representing variants at 5 and 173 weeks post-infection. The transmitted founder (TF) had significantly better pseudovirus entry efficiency than the chronic infection (CI) variant. Deletion of all PNGs significantly reduced TF entry efficiency, binding to dendritic cell-specific intracellular adhesion molecule 3 grabbing non-integrin (DC-SIGN) receptor and trans-infection. However, mutational analysis did not affect the phenotype of the CI Envelope to the same extent. Notably, deletion of the PNGs at N241 and N448 had no effect on CI Envelope function, suggesting that some PNGs might only be important during acute infection. Therefore, vaccines that elicit antibodies against N-glycans important for TF Envelope function could drive the loss of PNGs during immune escape, abrogating viral replication. Conversely, changes in N-glycosylation might have no effect on some variants, reducing vaccine efficacy. This finding highlights the need for further investigation into the role of Envelope N-glycosylation in HIV-1 pathogenesis.
format Online
Article
Text
id pubmed-6580609
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65806092019-06-24 HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression Lumngwena, Evelyn Ngwa Shuping, Liliwe Bernitz, Netanya Woodman, Zenda BMC Res Notes Research Note OBJECTIVE: As part of a larger study to understand how Envelope N-glycosylation influences HIV-1 pathogenesis, we selected a participant infected with a single Subtype C variant and determined whether deletion of specific potential N-glycan sites (PNGs) impacted Envelope function longitudinally. RESULTS: We deleted five PNGs previously linked to HIV-1 transmission of two matched Envelope clones representing variants at 5 and 173 weeks post-infection. The transmitted founder (TF) had significantly better pseudovirus entry efficiency than the chronic infection (CI) variant. Deletion of all PNGs significantly reduced TF entry efficiency, binding to dendritic cell-specific intracellular adhesion molecule 3 grabbing non-integrin (DC-SIGN) receptor and trans-infection. However, mutational analysis did not affect the phenotype of the CI Envelope to the same extent. Notably, deletion of the PNGs at N241 and N448 had no effect on CI Envelope function, suggesting that some PNGs might only be important during acute infection. Therefore, vaccines that elicit antibodies against N-glycans important for TF Envelope function could drive the loss of PNGs during immune escape, abrogating viral replication. Conversely, changes in N-glycosylation might have no effect on some variants, reducing vaccine efficacy. This finding highlights the need for further investigation into the role of Envelope N-glycosylation in HIV-1 pathogenesis. BioMed Central 2019-06-17 /pmc/articles/PMC6580609/ /pubmed/31208438 http://dx.doi.org/10.1186/s13104-019-4375-0 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Note
Lumngwena, Evelyn Ngwa
Shuping, Liliwe
Bernitz, Netanya
Woodman, Zenda
HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression
title HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression
title_full HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression
title_fullStr HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression
title_full_unstemmed HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression
title_short HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression
title_sort hiv-1 subtype c envelope function becomes less sensitive to n-glycosylation deletion during disease progression
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580609/
https://www.ncbi.nlm.nih.gov/pubmed/31208438
http://dx.doi.org/10.1186/s13104-019-4375-0
work_keys_str_mv AT lumngwenaevelynngwa hiv1subtypecenvelopefunctionbecomeslesssensitivetonglycosylationdeletionduringdiseaseprogression
AT shupingliliwe hiv1subtypecenvelopefunctionbecomeslesssensitivetonglycosylationdeletionduringdiseaseprogression
AT bernitznetanya hiv1subtypecenvelopefunctionbecomeslesssensitivetonglycosylationdeletionduringdiseaseprogression
AT woodmanzenda hiv1subtypecenvelopefunctionbecomeslesssensitivetonglycosylationdeletionduringdiseaseprogression